The Pharmacokinetics, and Safety of Brexpiprazole Tablets in Chinese Healthy Subjects
Status:
Completed
Trial end date:
2020-06-10
Target enrollment:
Participant gender:
Summary
This study is a single-center, open-label study evaluating the pharmacokinetics and safety of
multiple dose oral administration of Brexpiprazole (1 mg) tablets in Chinese healthy
subject.10 healthy adult subjects will be enrolled in this study. A single dose
(Brexpiprazole 1 mg) group is set and the test drug will be administered for 14 consecutive
days.